peroxisom
proliferatoractiv
receptor
gamma
ppar
agonist
rosiglitazon
inhibit
nfb
express
endogen
neural
stem
cell
differenti
neuron
reduc
inflammatori
cascad
spinal
cord
injuri
sci
aim
studi
explor
mechan
underli
rosiglitazonemedi
neuroprotect
effect
regul
balanc
inflammatori
cascad
gener
endogen
spinal
cord
neuron
use
spinal
cordderiv
neural
stem
cell
cultur
system
well
sd
rat
sci
model
activ
pparcould
promot
neural
stem
cell
prolifer
inhibit
pka
express
neuron
format
vitro
sd
rat
sci
model
rosiglitazon
forskolin
group
show
better
locomotor
recoveri
compar
rosiglitazon
forskolin
group
express
higher
rosiglitazon
forskolin
group
rosiglitazon
group
nfb
express
lower
rosiglitazon
forskolin
group
forskolin
group
neun
express
higher
rosiglitazon
forskolin
group
forskolin
group
pparactiv
like
inhibit
nfb
therebi
reduc
inflammatori
cascad
pka
activ
like
promot
neuron
cell
regener
acut
spinal
cord
injuri
sci
sever
often
perman
prove
expens
patient
commun
sci
highest
caus
death
young
peopl
year
age
current
treatment
proven
posit
effect
neurolog
outcom
follow
acut
sci
spinal
cord
injuri
result
primari
initi
damag
subsequ
secondari
damag
secondari
damag
due
earli
inflammatori
respons
spinal
cord
injuri
main
caus
neurolog
defect
exacerb
initi
degre
injuri
secondari
damag
usual
caus
ischemia
cellular
tissu
edema
oxid
damag
previou
research
found
activ
peroxisom
proliferatoractiv
receptorgamma
ppar
could
promot
locomotor
recoveri
spinal
cord
injuri
ppari
ppar
nuclear
receptor
subtyp
two
type
pparligand
natur
ligand
fatti
acid
eicosanoid
deriv
synthet
ligand
thiazolidinedion
keton
thiazolidinedion
tzd
rosiglitazon
rosiglitazon
pioglitazon
pioglitazon
use
clinic
medicin
treatment
type
diabet
rosiglitazon
part
thiazolidinedion
nuclear
hormon
receptor
superfamili
known
antiinflammatori
action
via
activ
ppar
rosiglitazon
attenu
express
proinflammatori
gene
cytokin
product
regul
ligand
activ
transcript
factor
rosiglitazon
neuroprotect
effect
neurodegen
diseas
spinal
cord
injuri
previous
report
applic
pparagonist
rosiglitazon
could
significantli
inhibit
activ
key
inflammatori
cascad
target
nuclear
transcript
factor
ppar
research
kappa
b
nuclear
factor
kappa
b
nfb
spinal
cord
injuri
nfb
extract
b
lymphocyt
name
bind
immunoglobulin
chain
gene
enhanc
sequencespecif
b
nfb
famili
transcript
factor
essenti
role
inflamm
innat
immun
activ
form
nfb
dimer
typic
heterodim
main
compon
nfb
famili
involv
gene
transcript
member
nfb
famili
particip
mani
physiolog
process
includ
regul
immun
respons
stimul
immun
cell
matur
product
surviv
essenti
transcript
factor
b
cell
preliminari
research
found
pparcould
inhibit
nfb
activ
promot
prolifer
inhibit
neural
differenti
endogen
neural
stem
cell
nfb
pparsign
pathway
close
relat
pparactiv
along
inhibit
nfbcytokin
cascad
could
protect
dextran
sulfat
sodiuminduc
coliti
mice
pparcould
also
attenu
inflamm
via
nfb
inhibit
lipopolysaccharideinduc
periton
addit
function
glucos
lipid
metabol
cell
prolifer
differenti
pparcan
also
allevi
acut
chronic
inflammatori
respons
nerv
injuri
amelior
neuron
apoptosi
ischem
brain
injuri
suppress
nfbdriven
transcript
imielski
et
al
report
distinct
loss
hippocamp
dentat
gyru
neuron
tissu
nfb
genedefici
mice
reactiv
nfb
could
promot
format
dentat
gyru
neuron
neural
network
improv
neuron
organ
anim
behavior
underli
mechan
like
relat
activ
camppka
activ
nfb
camp
cyclic
adenosin
monophosph
discov
earl
increas
level
camp
lead
transient
enhanc
transmitt
releas
regul
camp
cgmp
togeth
ensur
coordin
develop
one
axon
multipl
dendrit
pka
could
enhanc
transmitt
releas
synapt
connect
sensori
motor
neuron
pka
implic
growth
axon
surviv
newborn
neuron
forskolin
uniqu
diterpen
activ
cyclic
ampgener
system
forskolinmedi
activ
adenyl
cyclas
stimul
nerv
regener
vivo
sulaiman
et
al
found
treatment
forskolin
alon
combin
tgfresult
increas
number
regener
axon
compar
salineonli
control
find
consist
preliminari
find
activ
pparcould
inhibit
express
nfb
sd
rat
spinal
cord
injuri
model
inhibit
neuron
surviv
therefor
hypothes
pparactiv
sd
rat
inhibit
neuron
via
pka
downstream
nfb
vitro
experi
intend
verifi
pparactiv
inhibit
nfb
express
turn
could
inhibit
camppka
pathway
confirm
inhibit
camppka
ppar
anim
experi
initi
determin
whether
simultan
activ
pparand
pka
could
inhibit
inflamm
promot
neuron
format
studi
explor
role
pparand
pka
function
recoveri
spinal
cord
injuri
sd
rat
aim
determin
mechan
underli
recoveri
well
balanc
inflammatori
cascad
gener
endogen
spinal
cord
neuron
stem
cell
onedayold
sd
rat
kill
cervic
disloc
immers
alcohol
three
set
eye
scissor
tweezer
prepar
sequenc
place
beaker
alcohol
number
respect
skin
cut
use
first
scissor
side
spine
cut
rib
fossa
bottom
remov
modifi
fascia
fat
tissu
attach
spine
use
second
scissor
ml
serumfre
medium
drawn
ml
syring
syring
needl
flush
one
end
spine
wash
time
repeatedli
flush
spinal
cord
spinal
cord
cut
piec
use
third
pair
scissor
piec
spinal
cord
tissu
remov
petri
dish
fill
cultur
medium
subject
repeat
aspir
use
syring
form
uniform
suspens
spinal
cord
piec
siev
siev
order
separ
singl
cell
suspens
serumfre
sampl
centrifug
min
rpm
cell
stain
trypan
blue
count
seed
densiti
cell
ml
cultur
flask
incub
c
co
humidifi
atmospher
cultur
medium
chang
day
half
peculiar
nerv
ball
format
observ
use
invert
microscop
day
spinal
cordderiv
stem
cell
prolifer
expand
vitro
passag
cell
separ
mechan
use
pipett
siev
centrifug
min
supernat
discard
ml
spinal
cordderiv
stem
cell
inocul
onto
surfac
petri
dish
incub
medium
contain
ngml
b
fgf
ngml
egf
freeserum
cultur
system
use
order
screen
nsc
time
medium
chang
everi
passag
flask
chang
discard
adher
cell
thu
nsc
natur
purifi
cultiv
process
puriti
qualiti
nsc
calcul
stain
nestindapi
neural
stem
cell
deriv
spinal
cord
divid
three
group
name
rosiglitazon
group
treat
rosiglitazon
moll
dmso
abcam
group
treat
pparantagonist
moll
dmso
vehicl
group
treat
dmso
day
continu
cultur
prolifer
nsc
evalu
cell
number
use
cellomet
auto
usa
nexcelom
neural
stem
cell
grown
medium
supplement
fetal
bovin
serum
medium
use
induc
differenti
earli
neuron
marker
detect
qrtpcr
western
blot
membran
incub
h
horseradish
peroxidaselabel
secondari
antibodi
wash
expos
ecl
color
develop
reagent
membran
develop
use
chemidocit
tm
imag
system
biorad
rel
optic
densiti
analyz
use
softwar
nation
institut
health
bethesda
md
usa
product
camp
determin
elisa
rosiglitazon
treatment
supernat
neural
stem
cell
cultur
harvest
camp
level
determin
use
elisa
kit
gbd
co
accord
manufactur
instruct
anim
sd
rat
hous
temperaturecontrol
room
c
injur
rat
underw
manual
bladder
express
twice
day
halothan
anesthesia
induct
mainten
oxygen
nitrou
oxid
mixtur
sci
induc
adult
femal
spraguedawley
rat
drop
impactor
g
weight
rod
mm
diamet
height
mm
previous
report
laminectomi
perform
figur
sci
rat
randomli
divid
group
vehicl
group
n
rosiglitazon
group
n
forskolin
group
n
rosiglitazon
forskolin
group
n
rosiglitazon
mgkg
abcam
vehicl
pb
inject
ip
min
h
h
sci
forskolin
mgkgd
abcam
inject
ip
continu
day
motor
function
recoveri
sci
studi
use
bassobeattiebresnahan
locomotor
rate
scale
bbb
scale
spontan
hind
limb
movement
score
score
indic
normal
locomot
ensur
anim
began
score
rat
test
prior
injuri
rat
test
h
day
injuri
day
anim
euthan
rat
score
min
two
observ
blind
studi
group
harvest
three
rat
group
anesthet
chloral
hydrat
mlkg
damag
spinal
cord
cm
center
injuri
point
immedi
remov
day
surgeri
spinal
cord
tissu
harvest
dissoci
trypsin
mgml
collagenas
mgml
separ
debri
cell
describ
previou
studi
total
rna
mm
long
spinal
cord
segment
contain
injuri
epicent
obtain
group
extract
use
trizol
invitrogen
usa
injuri
rna
detect
electrophoresi
revers
transcript
result
show
degrad
cdna
reversetranscrib
use
revert
aidfirst
strand
cdna
synthesi
kit
thermo
scientif
cdna
use
templat
revers
transcript
polymeras
chain
reaction
analysi
rtpcr
amplif
method
use
data
analysi
target
gene
express
normal
dehydrogenas
gapdh
primer
forward
aacataccaccagccctttg
revers
nfb
forward
revers
neun
forward
revers
express
spinal
cord
tissu
cm
isol
use
lesion
site
epicent
spinal
cord
tissu
homogen
ripa
lysi
buffer
phosphatas
proteas
inhibitor
benzamidin
leupeptin
gml
na
vo
sodium
pyrophosph
phenylmethylsulfonyl
fluorid
tissu
homogen
incub
min
c
centrifug
c
protein
quantifi
bicinchonin
acid
protein
assay
kit
thermo
scientif
g
protein
load
lane
sampl
electrophores
onto
sodium
dodecyl
sulfatepolyacrylamid
gel
sdspage
transfer
pvdf
membran
millipor
massachusett
usa
block
bsa
tbst
mm
trishcl
salin
tween
room
temperatur
h
membran
incub
follow
primari
antibodi
c
overnight
antigapdh
abcam
abcam
antinfb
abcam
antineun
abcam
membran
incub
horseradish
peroxidaseconjug
secondari
antibodi
abcam
h
c
experi
lowtemperatur
environ
strictli
guarante
proteas
inhibitor
ad
ensur
protein
qualiti
membran
develop
use
chemidocit
tm
imag
system
rel
optic
densiti
analyz
use
quantiti
one
softwar
biorad
pka
determin
product
pka
determin
elisa
supernat
spinal
cord
tissu
harvest
pka
express
determin
use
elisa
kit
gbd
co
accord
manufactur
instruct
statist
analys
conduct
use
spss
softwar
bbb
score
anim
averag
use
determin
group
mean
day
bbb
score
data
express
mean
sd
comparison
among
group
perform
oneway
analysi
varianc
anova
follow
tukeykram
multipl
comparison
post
hoc
test
spinal
cord
light
microscop
primari
neural
cell
appear
round
small
cell
bodi
singl
scatter
shini
halo
cell
grew
suspens
form
neural
stem
cell
sphere
cell
grew
adher
day
dozen
clone
sphere
form
suspens
cell
cluster
clone
sphere
show
spheric
shape
obviou
protrus
three
day
inocul
nsc
deriv
rat
spinal
cord
rapidli
prolifer
form
cellular
sphere
neural
sphere
figur
immunofluoresc
stain
show
nestin
express
neurospher
cytoplasm
color
seen
immunofluoresc
stain
perform
identifi
neural
stem
cell
nestin
dapi
figur
cell
prolifer
tabl
show
number
ensc
pparactiv
second
gener
nsc
select
group
cultur
ad
rosiglitazon
moll
moll
cell
cultur
day
nsc
three
group
prolifer
nsc
prolifer
rosiglitazon
group
significantli
greater
neg
control
group
p
nsc
prolifer
group
clearli
neutral
signific
differ
nsc
number
neg
control
rosiglitazon
group
stem
cell
examin
mrna
express
pka
comparison
nsc
number
three
group
experi
repeat
least
three
time
p
n
signific
differ
rosiglitazon
group
neg
control
group
statist
method
oneway
anova
follow
pairwis
comparison
holmsidak
method
figur
figur
b
nfb
figur
c
three
group
pka
mrna
express
rosiglitazon
group
lower
vehicl
activ
ppari
block
express
pka
restor
rosiglitazon
group
p
n
express
mrna
rosiglitazon
group
lower
vehicl
activ
ppari
block
inhibit
could
partli
revers
rosiglitazon
group
p
n
compar
vehicl
rosiglitazon
group
express
nfb
mrna
significantli
decreas
activ
pparin
rosiglitazon
group
p
n
wb
experi
observ
similar
trend
indic
group
activ
pparcould
inhibit
pka
express
figur
j
express
rosiglitazon
group
lower
vehicl
rosiglitazon
group
p
n
express
neuron
format
marker
protein
figur
e
j
significantli
decreas
ad
rosiglitazon
lower
rosiglitazon
group
rosiglitazon
vehicl
group
p
n
compar
vehicl
rosiglitazon
group
express
nfb
protein
figur
f
j
significantli
decreas
rosiglitazon
group
p
n
respect
elisa
experi
camp
level
cell
treat
rosiglitazon
rosiglitazon
group
lower
vehicl
group
use
block
activ
ppar
camp
level
rosiglitazon
group
higher
rosiglitazon
group
figur
h
effect
promot
locomotor
recoveri
rat
bbb
score
sci
lost
locomotor
function
h
sci
h
point
bbb
score
group
still
day
compar
vehicl
rosiglitazon
forskolin
group
rosiglitazon
group
show
significantli
higher
bbb
score
p
n
day
compar
vehicl
group
rosiglitazon
forskolin
group
show
significantli
higher
bbb
score
p
n
rosiglitazon
forskolin
group
also
show
higher
bbb
score
forskolin
rosiglitazon
group
respect
p
n
day
group
show
highest
bbb
score
sinc
sci
bbb
score
respect
vehicl
forskolin
rosiglitazon
forskolin
rosiglitazon
group
p
n
figur
day
spinal
cord
injuri
pka
activ
forskolin
express
higher
forskolin
group
figur
three
group
p
n
pparagonist
rosiglitazon
neg
regul
neuron
format
rosiglitazon
group
p
n
show
lowest
express
rosiglitazon
could
inhibit
inflamm
promot
matur
neuron
surviv
combin
pka
agonist
forskolin
express
matur
neuron
marker
neun
figur
b
forskolin
rosiglitazon
group
rosiglitazon
group
higher
group
use
forskolin
alon
show
protect
effect
matur
neuron
surviv
lowest
express
neun
found
forskolin
group
rosiglitazon
critic
inhibit
inflammatori
respons
express
inflamm
marker
nfb
figur
c
lowest
rosiglitazon
group
pparand
pka
simultan
activ
express
nfb
forskolin
rosiglitazon
group
still
lower
forskolin
group
vehicl
group
follow
sci
indic
group
wb
experi
rtpcr
express
figur
j
higher
forskolin
group
vehicl
rosiglitazon
group
express
higher
forskolin
rosiglitazon
group
rosiglitazon
group
pparwa
activ
rosiglitazon
alon
rosiglitazon
group
pparand
pka
simultan
activ
forskolin
rosiglitazon
group
nfb
express
figur
f
j
lower
two
group
vehicl
group
forskolin
group
nfb
express
forskolin
rosiglitazon
rosiglitazon
group
signific
differ
rosiglitazon
combin
forskolin
best
protect
effect
matur
neuron
surviv
express
neun
figur
e
j
forskolin
rosiglitazon
group
compar
vehicl
group
forskolin
group
pparwa
activ
rosiglitazon
alon
express
neun
rosiglitazon
group
higher
forskolin
vehicl
group
pka
express
forskolin
group
higher
group
effect
decreas
pparand
pka
simultan
activ
forskolin
rosiglitazon
group
forskolin
rosiglitazon
group
still
show
higher
pka
express
rosiglitazon
vehicl
group
figur
h
consid
effect
rosiglitazon
nfb
data
suggest
rosiglitazon
like
inhibit
pka
nfb
rosiglitazon
use
alon
express
pparin
rosiglitazon
group
higher
vehicl
forskolin
group
differ
found
rosiglitazon
group
rosiglitazon
forskolin
rf
group
figur
b
studi
undertaken
evalu
effect
simultan
activ
pparand
pka
promot
locomotor
recoveri
sd
rat
express
inflammatori
factor
individu
activ
pparand
pka
simultan
could
also
inhibit
express
inflammatori
factor
nfb
protect
matur
neuron
prolif
sourc
neural
stem
cell
includ
telencephalon
lu
et
al
report
presenc
neural
stem
cell
around
ependym
membran
spinal
cord
result
verifi
presenc
neural
stem
cell
spinal
canal
moralesgarcia
found
activ
pparcould
promot
neural
stem
cell
prolifer
vitro
could
verifi
activ
pparpromot
prolifer
spinal
cordderiv
neural
stem
cell
vitro
revers
pparactiv
inhibit
interact
pparand
nfb
implic
certain
central
neural
diseas
pparcan
inhibit
activ
nfb
bind
subunit
nfb
compet
common
transcript
coactiv
crebbind
protein
upregul
inhibitor
kappa
b
b
protein
prevent
nfb
nuclear
transloc
prerequisit
nfb
activ
pparcould
also
indirectli
inhibit
nfb
activ
transcript
factor
reduc
gener
prooxid
molecul
requir
nfb
activ
ppartherefor
mediat
inhibit
nfb
therebi
reduc
central
nervou
system
inflammatori
cascad
effect
neuroprotect
condit
induc
differenti
found
pparactiv
express
nfb
inhibit
pka
express
also
inhibit
process
restor
pparwa
inhibit
like
relat
ppar
mediat
inhibit
nfb
sinc
pka
found
downstream
nfb
howev
feedback
mechan
clear
substrat
pka
play
import
role
axogenesi
koichiro
et
al
suggest
activ
pparbi
rosiglitazon
stimul
nsc
growth
inhibit
differenti
nsc
neuron
found
pparactiv
neural
stem
cell
differenti
induct
system
inhibit
express
consist
result
koichiro
result
confirm
inhibitori
effect
pparon
neuron
differenti
spinal
cordderiv
neural
stem
cell
could
occur
via
nfb
pka
vitro
order
show
inhibit
camp
pathway
rosiglitazon
camp
level
cell
measur
elisa
see
chang
camp
level
consist
chang
pka
level
order
confirm
pparand
pka
activ
sci
protein
express
pparand
pka
observ
vivo
found
correspond
increas
express
pparand
pka
appli
rosiglitazon
forskolin
respect
use
neun
vivo
marker
matur
neuron
surviv
follow
sci
neun
antigen
use
wide
research
diagnost
identifi
postmitot
neuron
present
studi
observ
neun
express
forskolin
group
lower
rosiglitazon
forskolin
rosiglitazon
group
suggest
rosiglitazon
inhibit
inflamm
combin
forskolin
promot
neuron
format
best
protect
effect
matur
neural
stem
cell
surviv
forskolin
alon
effect
surviv
matur
neuron
inflammatori
cascad
follow
spinal
cord
injuri
marker
dendrit
lesion
cn
injuri
extrem
sensit
mani
factor
recent
investig
reveal
dynam
function
growth
differenti
plastic
neuron
discoveri
indic
modif
rearrang
earli
obligatori
step
mani
process
modifi
neuron
function
present
experi
studi
observ
express
forskolin
group
higher
rosiglitazon
forskolin
rosiglitazon
group
like
relat
activ
pka
pka
implic
growth
axon
surviv
newborn
neuron
thu
forskolin
like
play
import
role
promot
neuron
format
rosiglitazon
neg
regul
neuron
format
also
examin
express
camp
vitro
pka
vivo
consist
express
suggest
forskolin
affect
neuron
format
camppka
compar
rest
control
group
higher
express
neun
spinal
cord
injuri
segment
neuroprotect
genistein
oxid
stress
injuri
cortic
neuron
occur
via
inhibit
nfb
jnk
erk
signal
pathway
adult
mammalian
brain
nfb
activ
seem
crucial
regul
structur
plastic
replenish
granul
cell
within
hippocampu
throughout
life
suggest
inhibit
express
nfb
key
strategi
inhibit
secondari
inflammatori
cascad
promot
locomotor
recoveri
sd
rat
spinal
cord
injuri
activ
pparinhibit
nfb
express
sd
rat
spinal
cord
injuri
model
genet
ablat
nfb
result
sever
defect
neurogen
region
dentat
gyru
hippocampu
reactiv
nfb
result
integr
newborn
neuron
eventu
regener
dentat
gyru
accompani
complet
recoveri
structur
behavior
defect
effect
attribut
nfbmediat
control
pka
transcript
regul
axogenesi
sulaiman
et
al
found
forskolin
could
attenu
advers
effect
longterm
schwann
cell
denerv
peripher
nerv
regener
vivo
forskolin
protect
effect
behavior
deficit
neuropatholog
chang
mous
model
cerebr
amyloidosi
could
contribut
effici
product
daergic
neuron
humanderiv
npc
therapi
neurodegen
diseas
present
studi
found
forskolin
could
improv
number
nerv
dendrit
marker
sd
rat
spinal
cord
injuri
model
consist
aforement
find
process
observ
forskolin
increas
express
pka
also
confirm
effect
forskolin
neuron
format
pka
present
studi
found
simultan
activ
pparand
pka
elicit
best
result
term
bbb
score
howev
simultan
activ
pparand
pka
efficaci
activ
pka
alon
promot
gener
newborn
neuron
activ
pparalon
inhibit
inflamm
recoveri
locomotor
function
spinal
cord
injuri
rat
like
relat
secondari
damag
caus
inflammatori
cascad
well
neuron
cell
regener
injuri
balanc
two
therefor
import
achiev
combin
inhibit
nfb
surviv
gener
neuron
activ
pparand
pka
simultan
could
produc
best
result
term
promot
motor
function
spinal
cord
injuri
sd
rat
underli
mechan
like
involv
ppar
mediat
inhibit
nfb
consequ
amelior
inflammatori
cascad
pkamedi
promot
neuron
cell
format
data
use
support
find
studi
avail
correspond
author
upon
request
author
declar
conflict
interest
